Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED) [Phase 3]
The extension study (0653A-038) of an investigational drug for hypercholesterolemia has completed, with Organon and Co listed as sponsor.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
A completed real-world study evaluating Inclisiran in Chinese adults with primary hypercholesterolemia or mixed dyslipidemia.
-
CLINICAL_TRIALS research · 2024-07-19Clinical Trial Update: PET Imaging of Inflammation and Lipid Lowering Study [NA]
This is a clinical trial update indicating that a PET imaging study of inflammation and lipid lowering (NCT04073797) sponsored by the Univer…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial Hypercholesterolemia
This completed real-world study evaluated adherence, treatment patterns, patient characteristics, and effectiveness of Inclisiran in patient…
-
FDA approval · 2024-07-11FDA Approved: FLUVASTATIN SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for Fluvastatin Sodium (generic) from Lannett Company, Inc., confirming regulatory approval for this…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-07-11FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for atorvastatin calcium from NorthStar RxLLC, resulting in the approval of a generic atorvastatin c…
-
FDA approval · 2024-07-10FDA Approved: EZETIMIBE — Supplemental Application (Marlex Pharmaceuticals, Inc.)
The FDA approved a supplemental application for ezetimibe submitted by Marlex Pharmaceuticals, Inc., granting an update to the approved gene…
-
FDA approval · 2024-07-10FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic Ezetimibe and Simvastatin combination from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy [Phase 2]
Phase 2 study evaluating obicetrapib in combination with ezetimibe as an adjunct to HIS therapy has completed, with results posted in July 2…
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Plant Sterols on Cardiovascular Markers, Microbiota and Sterol Metabolism (Cardiofoodsterol) [NA]
Clinical trial update indicating recruitment is ongoing for Cardiofoodsterol, a study evaluating the effects of plant sterols on cardiovascu…
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Effect of the Food Supplement TOTUM-070 on Lipid Metabolism [NA]
Clinical trial update on TOTUM-070 evaluating its effects on lipid metabolism in adults with hypercholesterolemia. The trial is currently ac…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects [Phase 1]
Phase 1 bioequivalence study comparing Crecheck Tablet 2.5 mg rosuvastatin calcium with Crestor Tablet 5 mg rosuvastatin calcium in healthy …
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: HealthMatters@24/7 eLearning for People Supporting Adults With Intellectual and Developmental Disabilities [NA]
The HealthMatters@24/7 eLearning trial for supporting adults with intellectual and developmental disabilities has completed, studying outcom…
-
FDA approval · 2024-06-17FDA Approved: EZETIMIBE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for ezetimibe from Ascend Laboratories, LLC.
-
FDA approval · 2024-06-14FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for atorvastatin calcium from NorthStar RxLLC, authorizing a generic version of atorvastatin.
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Randomized Study of Obicetrapib as an Adjunct to Statin Therapy [Phase 2]
Phase 2 randomized study of Obicetrapib added to statin therapy has completed with results posted.
-
FDA approval · 2024-06-11FDA Approved: PITAVASTATIN — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for pitavastatin from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Evaluating the Efficacy of AI-Guided (GenAIS TM) vs. Standard Physician-Guided Dietary Supplement Prescriptions for Lowering LDL Cholesterol in Hypercholesterolemic Patients [NA]
A completed clinical trial evaluated whether AI-guided dietary supplement prescriptions (GenAIS) lower LDL cholesterol more effectively than…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093) [Phase 4]
A Phase 4 trial comparing the combination of ezetimibe and simvastatin versus atorvastatin in patients with diabetes mellitus or metabolic s…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022 [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of co-administered AD-2021 and AD-2022 has completed.
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Chart Review of Repatha® in Subjects With Hyperlipidaemia
This is a completed chart-review study evaluating the use of Repatha (evolocumab) in subjects with hyperlipidemia and/or hypercholesterolemi…
-
FDA approval · 2024-06-03FDA Approved: EZETIMIBE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ezetimibe from Aurobindo Pharma Limited, confirming regulatory approval of this generic ezetimib…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: The Impact of Chokeberry Bioproducts on Metabolic Parameters and Antioxidant Potential [NA]
This completed clinical trial investigated chokeberry bioproducts and their effects on metabolic parameters and antioxidant potential in par…
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women [Phase 2, Phase 3]
A clinical trial is evaluating a phytoestrogen extract from Pueraria mirifica for improving serum lipid parameters in postmenopausal women, …
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: Effect of a Customised Lifestyle Medicine Strategy on Lowering Blood Lipid Levels in Indian Physicians [NA]
This clinical trial update reports on a study evaluating a customized lifestyle medicine approach to lower lipid levels in Indian physicians…